Recombinant Human ITLN1 protein ab157030 from Abcam

Discovery Drive

Cambridge Biomedical Campus

Cambridge CB2 0AX

United Kingdom

Phone: +44 (0) 1223 696000 (option 1)
+44 (0) 1223 696000 (option 2)
+44 (0) 1223 771600

(1) Omentin-1 protects against endothelial dysfunction through the AMPK/KLF2/eNOS pathway in adult rat offspring exposed to maternal diabetesNutr DiabetesJuly 28, 2025ChunXiang Wang, QingHua Wang, HaoShan Maithe age of 24 weeks were intraperitoneally injected recombinant human omentin-1 protein (rh-omentin, ab157030, Abcam, USA) at 18 μg/kg/day [18] or saline (1 ml/day) as vehicle for 6 weeks, arranged as CMO+omentin-1

(2) Therapeutic potential of omentin-1 in preeclampsia: enhancing fetal outcomes, vascular function, and reducing inflammationExperimental animalsApril 20, 2025Song M, Jiao B, Tian XJ, Qi BR.similar pump at the same rate. Rh-omentin treatment Recombinant human omentin-1 protein (rh-omentin, ab157030, Abcam, Cambridge, MA, USA) at 25 µg/kg/day or an equal volume of PBS was injected intraperitoneally

(3) Omentin-1 Modulates Macrophage Function via Integrin Receptors αvβ3 and αvβ5 and Reverses Plaque Vulnerability in Animal Models of AtherosclerosisFrontiers in cardiovascular medicineJanuary 1, 2021Lin X, Sun Y, Yang S, Yu M, Pan L, Yang J, Yang J, Shao Q, Liu J, Liu Y, et al.California, United States) were used to achieve the continuous infusion of the flag-tagged omentin-1 (Abcam, ab157030, UK) solution into the mouse jugular vein. For implanting the minipumps, anesthesia was induced to the

Recombinant Human ITLN1 protein from Abcam